HB 681 directs the Commission for Mental Health, Developmental Disabilities, and Substance Use Services to update state rules for outpatient opioid treatment programs (OTPs). The bill aims to align these rules more closely with federal regulations governing medications for opioid use disorder, affecting patients receiving treatment and the OTPs providing care. Key changes include removing home environment stability as a criterion for take-home medication and prohibiting administrative discharge due to continued substance use or missed doses. It also reduces the frequency of required drug tests, removes observed testing, and allows OTPs to administer methadone to non-enrolled patients. The Commission must engage with clients and providers for input and publish the proposed amended rules by July 1, 2025.
HB 156 sets minimum standards for stop loss, catastrophic, and reinsurance coverage provided to small employers in North Carolina. It directly affects small employers (defined as those with fewer than 12 eligible employees) and insurers selling these specific insurance products. The bill requires insurers to maintain a minimum annual attachment point of $20,000 per individual (adjusted annually using the Consumer Price Index) and a minimum aggregate attachment point of either 120% of expected claims or $20,000 per year. These standards apply to all new, renewed, or amended insurance contracts issued on or after October 1, 2025.
House Bill 107 designates the second week of November each year as Sudden Unexpected Death in Epilepsy (SUDEP) Awareness Week in North Carolina. Additionally, it encourages local boards of education to develop and offer seizure awareness training for school personnel who are responsible for students with epilepsy or who are otherwise predisposed to seizures. This training aims to provide school staff with information to support these students.
HB 152 aims to regulate how health benefit plans in North Carolina cover Transcranial Magnetic Stimulation (TMS) services. If an insurer chooses to cover TMS, the bill requires them to cover all procedures performed by properly licensed healthcare providers, regardless of their medical specialty, as long as TMS is within their scope of practice. It prohibits insurers from penalizing providers solely based on their specialty when submitting TMS claims. However, the bill maintains that insurers retain discretion over whether to cover TMS, for which conditions, and at what reimbursement rates.
House Bill 592, known as the Toxic-Free Medical Devices Act of 2025, aims to prohibit the use of a chemical called DEHP in certain medical devices within North Carolina. Specifically, it bans the manufacturing, selling, and distributing of intravenous solution containers and intravenous tubing that are intentionally made with DEHP. The prohibition for IV solution containers takes effect on January 1, 2030, and for IV tubing on January 1, 2035. The bill also prevents replacing DEHP with other similar chemicals in these devices and sets limits for unintentionally present DEHP, while exempting certain blood-related products. Violations of these provisions could lead to administrative penalties.
HB 160 requires North Carolina's University of North Carolina School of Medicine Area Health Education Centers (NC AHEC) to create and share evidence-based information about sudden unexpected death in epilepsy (SUDEP) with all healthcare practitioners in the state. This includes current risk factors, conditions, and contact details for epilepsy support organizations, available on NC AHEC's website. Healthcare providers treating epilepsy patients will directly receive this standardized resource, which must be compiled by consulting medical boards and professional societies. NC AHEC must report the completed resource to the legislature by September 1, 2025.
